Struggling Alzheimer's Researcher Charged with Fraud
A scientist whose research was at the center of a controversy over a potential Alzheimer's drug has been charged with fraud.A federal grand jury on Thursday indicted Hoau-Yan Wang, a professor at the City College of New York, on charges of falsifying data to obtain grants totaling about $16 million from the National Institutes of Health.Dr. Wang’s studies have supported research on a diagnostic test for Alzheimer’s disease and on simufilam, a drug in late-stage clinical trials. Simufilam’s maker, Cassava Sciences, a Texas-based pharmaceutical company, has claimed that the drug improves cognition in Alzheimer’s patients.Alzheimer's disease affects about six million Americans, a number that is expected to double by 2050, and promising treatments generate enormous excitement. Cassava&...